This text is a result of machine translation.
F-star to be acquired by China biopharmaceutical with USD 161million
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
WIM 2022: Transcript of Fireside Chat of Biotech [1/2]
EqualOcean organized the WIM2022 event in New York City from July 29 to July 30, 2022. The following is the transcript for Fireside Chat of Biotech. Leon Tang, Bing Yuan, Ying Huang, Dahai Guo, and Sally Wang are the five guest speakers in this chat.
Aug 05, 2022 09:11 PM
East China medicine "liraglutide" goes to sea
Research
Consumer Staples, Technology, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Technology, Real Estate, Consumer DiscretionaryTech for Global, Globalization Footprints of the Established and the New
Research
Technology, Real Estate, IndustrialsLow-Carbon Industry Expansion - Key Studies From Chinese Companies
Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care
Baiyunshan: suspension of the spin off of Guangzhou Pharmaceutical for overseas listing
Germany Merck "cetuximab" new indications for head and neck squamous cell carcinoma approved in China
Yanye new crown drug 3CL protein inhibitor has been suspended approval
Bennu Biotherapeutics Bags Over CNY 100 Mn in Angel+ Financing Round
Biotech Bennu Biotherapeutics, focusing on the R&D and conversion of cutting-edge technologies in the cell therapy, will continue to contribute to global innovative cellular therapies for oncology and autoimmune diseases with the fresh proceeds.
Aug 15, 2022 05:19 PM
Sanofi Greater China will be headed by Shi Wang, and Henting he will become the global head of the digital business unit
Acadia Alzheimer's drug SNDA application rejected by FDA advisory committee
Huashen Zhiyao completed nearly 500million yuan of a-round financing and went deep into AI new drug development
Trautec Medical Raises Nearly CNY 200 Mn in Series A Financing Round
Trautec Medical, dedicated to developing and producing recombinant collagen-based biomaterials, will continue to focus on the innovation of biomaterials and strive to integrate resources from all sides.
Aug 12, 2022 06:12 PM
Huamei Haolian, a health management service enterprise, completed round a+ financing, and Jinshajiang venture capital led the investment
Mojia biology announced the completion of round B financing
First class recall of Draeger, a ventilator giant
The state plans to prohibit third-party platforms from directly participating in online drug sales
A Quick Look at The Semiconductor Industry: 60 Players of Key Fields [2/2]
Aug 15, 2022 05:01 PM